Intelligencia AI

Drug development is expensive and most candidates fail, so pharma teams need better ways to judge which programs deserve more money.

Intelligencia AI is a business research tool that uses AI to de-risk drug development and support decisions about what to pursue.

It predicts the likelihood that a drug will succeed across multiple therapeutic areas, and companies use those predictions to shape portfolio strategy and cut avoidable risk in clinical development.

Intelligencia AI sits in the AI healthcare and AI predictions space, and it also falls under AI consulting and data analytics.

That makes it relevant to people who work in pharmaceutical strategy, clinical planning or research and need forecasts to back up a choice rather than gut feel.

Intelligencia AI presents itself as a suite of solutions, not a single product, so expect to work through the company to see what fits your pipeline.

Pricing is not something you can judge from the website alone.